Palo Alto Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,611,787
Closed -$8.37M 47
2024
Q3
$8.37M Sell
1,611,787
-3,645,299
-69% -$18.9M 1.09% 19
2024
Q2
$13.5M Buy
5,257,086
+9,082
+0.2% +$23.3K 1.57% 13
2024
Q1
$25.8M Buy
5,248,004
+10,720
+0.2% +$52.7K 2.91% 12
2023
Q4
$46M Buy
5,237,284
+8,675
+0.2% +$76.3K 4.15% 8
2023
Q3
$60M Hold
5,228,609
5.67% 7
2023
Q2
$132M Sell
5,228,609
-41,600
-0.8% -$1.05M 10.69% 3
2023
Q1
$170M Sell
5,270,209
-13,400
-0.3% -$432K 14.06% 2
2022
Q4
$97.5M Buy
5,283,609
+878,570
+20% +$16.2M 8.32% 7
2022
Q3
$119M Hold
4,405,039
9.4% 5
2022
Q2
$60.9M Sell
4,405,039
-10,650
-0.2% -$147K 5.31% 8
2022
Q1
$86.1M Buy
4,415,689
+46,323
+1% +$903K 6.66% 7
2021
Q4
$71.3M Buy
4,369,366
+1,167,500
+36% +$19.1M 4.56% 9
2021
Q3
$89.2M Hold
3,201,866
5.38% 9
2021
Q2
$94.9M Hold
3,201,866
5.23% 8
2021
Q1
$89.5M Buy
3,201,866
+528,553
+20% +$14.8M 5.1% 8
2020
Q4
$75.8M Buy
2,673,313
+678,408
+34% +$19.2M 3.97% 10
2020
Q3
$50.2M Buy
1,994,905
+290,533
+17% +$7.3M 2.75% 12
2020
Q2
$41.6M Buy
1,704,372
+1,088,667
+177% +$26.6M 2.5% 15
2020
Q1
$9.11M Buy
615,705
+527,115
+595% +$7.8M 0.76% 20
2019
Q4
$1.44M Buy
+88,590
New +$1.44M 0.08% 28
2014
Q4
Sell
-80,369
Closed -$1.55M 48
2014
Q3
$1.55M Sell
80,369
-11,300
-12% -$218K 0.12% 38
2014
Q2
$3.12M Hold
91,669
0.23% 36
2014
Q1
$2.89M Buy
+91,669
New +$2.89M 0.24% 29